"What I think we're going to hear from the FDA advisory committee is a go-ahead to boost people over the age probably of 60 because that's where the data is most solid," CNN Medical Analyst Dr. Jonathan Reiner said.
from Google Alert - health https://ift.tt/3tOZTe0
via IFTTT
0 comments:
Post a Comment